Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer.
about
Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Pancreatic Lesions: A Systematic Review of Technical and Procedural VariablesClinical approach to incidental pancreatic cystsPrevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future DirectionsGlycoproteins and glycoproteomics in pancreatic cancerEndosonography in the diagnosis and management of pancreatic cystsIdentification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer.Proteome Characterization of Human Pancreatic Cyst Fluid from Intraductal Papillary Mucinous Neoplasm by LC/MS/MS.Systematic Review of Pancreatic Cyst Fluid Biomarkers: The Path Forward.Novel Biomarkers for Pancreatic Cysts.Imaging modalities for characterising focal pancreatic lesions.Cystic tumors of the pancreas: Opportunities and risks.Endoscopic Management of Pancreatic Cysts.Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas.Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.EUS-guided reverse bevel fine-needle biopsy sampling and open tip fine-needle aspiration in solid pancreatic lesions - a prospective, comparative study.Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.Proteomic biomarkers in body fluids associated with pancreatic cancer.
P2860
Q26751417-95B9EEBF-C5BC-4298-B316-619D995DFB17Q26774489-FE757E0E-F18D-4CE9-8357-4304FA78C487Q26783953-63AF1040-3AD0-4146-9257-4DDB4F82CBC2Q28071108-3FB48601-B1F2-4D3D-9C30-A1732CF4C2A6Q35179268-E343BF3D-0E77-4E36-8CF9-5C7D1CD44F8FQ35551996-9F6ADE1C-D7EF-4802-BB53-D15969EF711DQ38372053-0457479E-F620-4FDC-9AC3-4504EAEC6401Q38525151-84056361-315A-41C0-AB21-64B7B728BCA8Q38757526-0FDBC3A0-3737-4D42-A5D1-F46491FBDA9DQ38834240-8EBEC497-CD48-40FD-9C99-4C4BBE77EFC2Q39006342-2D2B6EBE-D4DC-4F15-94FF-41EC6171CB28Q39185564-AEBB3137-8A8D-40F2-97EF-F2CB6F92F6A2Q40377571-9EC228F1-96AD-4749-9E0D-662A37CD7FA1Q41135639-E16B51D2-63CE-45D5-9388-56E2A977081AQ41608507-A0B0F45B-2E5D-4C5D-A478-22B78069DA64Q47373659-01BEFD94-466B-4F5F-9344-BBF5F36E366FQ48308002-1FDC2C61-DA20-42DD-AE0B-E2D631970911Q51820838-341A2781-3FE3-48D0-BDD1-1B008928120FQ52584324-163EDD24-05BB-46A3-87FB-C5DF25665F1B
P2860
Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomic mucin profiling for ...... ecursors of pancreatic cancer.
@en
Proteomic mucin profiling for ...... ecursors of pancreatic cancer.
@nl
type
label
Proteomic mucin profiling for ...... ecursors of pancreatic cancer.
@en
Proteomic mucin profiling for ...... ecursors of pancreatic cancer.
@nl
prefLabel
Proteomic mucin profiling for ...... ecursors of pancreatic cancer.
@en
Proteomic mucin profiling for ...... ecursors of pancreatic cancer.
@nl
P2093
P2860
P50
P356
P1476
Proteomic mucin profiling for ...... recursors of pancreatic cancer
@en
P2093
Anders G Hyltander
Caroline Verbeke
Henrik Sjövall
P2860
P304
P356
10.1093/JNCI/DJT439
P407
P577
2014-02-01T00:00:00Z